Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells

Nedaplatin, a cisplatin analog, was developed to reduce the toxicity of cisplatin, whereas it can be cross-resistant with cisplatin in some circumstances. This study aimed to investigate the role of autophagy in nedaplatin induced cell death in cisplatin-resistant nasopharyngeal carcinoma cells. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhongyu, Liu, Jun, Li, Li, Nie, Dan, Tao, Qilei, Wu, Jian, Fan, Jiajun, Lin, Chen, Zhao, Shuwei, Ju, Dianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543554/
https://www.ncbi.nlm.nih.gov/pubmed/26288183
http://dx.doi.org/10.1371/journal.pone.0135236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543554/
https://www.ncbi.nlm.nih.gov/pubmed/26288183
http://dx.doi.org/10.1371/journal.pone.0135236

Ejemplares similares